Patents (1436 Stem Cell Patents)

Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair

Patent Number: 6890897

Date of First Priority Issue: Thursday January 28th, 1999
Date Issued: Tuesday May 10th, 2005
Assignee: Scil Technology GmbH (Martinsried, DE)
Inventors: Dony, Carola (Munchen, DE); Proetzel, Gabriele (Schwanfeld, DE); Leser-Reiff, Ulrike (Penzberg, DE)

From Class: Expansion
Comments: No comments

This patent teaches the novel use of melanoma inhibitory factor to induce stem cell differentiation into bone and cartilage. It may be used for in vitro generation of stem cells or for acceleration of in vivo healing. The independent claims of the patent are:

A method for inducing chondro-/ostrogenic lineage and promoting of cartilage or bone formation in a person comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, and at least one biocompatible or biodegradable matrix selected from the group consisting of hyaluronic acid, alginate, calcium sulfate, tricalcium phosphate, hydroxyapatite, polylactic-coglycolid, polyanhydrides and collagen to a person in need thereof.

A pharmaceutical composition comprising a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, in combination with an osteoinductive protein, wherein said osteoinductive protein is selected from the group consisting of BMP-2, BMP-7 and a hedgehog protein.

A method for inducing chondro-/ostrogenic lineage and promoting of cartilage or bone formation in a person comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, and at least one biocompatible and/or biodegradable matrix selected from the group consisting of hyaluronic acid, alginate, calcium sulfate, tricalcium phosphate, hydroxyapatite, polylactic-coglycolid, polyanhydrides and collagen, wherein the biocompatible matrix is at least one member selected from the group consisting of hyaluronic acid, alginate, collagen, heparin, polylactic-coglycolid and polyactic-coglycolid derivatives.

A method of inducting of the chondro-/osteogenic lineage and promoting cartilage and/or bone formation comprising administering an effective amount of a pharmaceutical composition comprising a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, at least one biocompatible or biodegradable matrix selected from the group consisting of hyaluronic acid, alginate, calcium sulfate, tricalcium phosphate, hydroxylapatite, polylactic-coglycolid, polyanhydrides and collagen, and an osteoinductive protein selected from the group consisting of BMP-2, BMP-7 and a hedgehog protein to a subject.

A method of treating or repairing at least one of bone or cartilage in a patient comprising administering to a patient in need of bone or cartilage treatment or repair, an effective amount of a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, to the patient to repair the bone or cartilage.

A pharmaceutical composition comprising a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, and a biocompatible matrix, wherein said biocompatible matrix is a three dimensional sponge prepared from collagen, alginate, tricalcium phosphate, and hydroxyapatite.

A method of treating or repairing at least one of bone or cartilage in a patient comprising administering an effective amount of a composition comprising a melanoma inhibiting activity factor, wherein said melanoma inhibiting activity factor is MIA, and an osteoinductive protein to the patient to repair the bone or cartilage.


View this patent on the USPTO website.

Added to StemCellPatents.com on Monday October 16th, 2006

Social & Bookmarking:Digg 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to del.icio.us Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Technorati Stumble 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Furl Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Reddit Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Blinklist Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Ma.gnolia Share 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' on Facebook Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Google Add 'Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair' to Yahoo Web 

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent